| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside monophosphate kinase activity | 1.51e-05 | 23 | 133 | 4 | GO:0050145 | |
| GeneOntologyMolecularFunction | fructose 1,6-bisphosphate 1-phosphatase activity | 4.40e-05 | 2 | 133 | 2 | GO:0042132 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, phosphate group as acceptor | 1.57e-04 | 41 | 133 | 4 | GO:0016776 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound kinase activity | 2.69e-04 | 47 | 133 | 4 | GO:0019205 | |
| Domain | ARM-type_fold | MROH9 TRPC4AP FHOD3 FRYL UNC45A ITPR1 FOCAD EIF5 DAAM1 AP4B1 GCN1 | 2.94e-05 | 339 | 132 | 11 | IPR016024 |
| Domain | Fructose_bisphosphatase_AS | 4.96e-05 | 2 | 132 | 2 | IPR020548 | |
| Domain | FBPtase | 4.96e-05 | 2 | 132 | 2 | IPR028343 | |
| Domain | RSBN1 | 4.96e-05 | 2 | 132 | 2 | IPR026306 | |
| Domain | FBPase_N | 4.96e-05 | 2 | 132 | 2 | IPR033391 | |
| Domain | FBPase | 4.96e-05 | 2 | 132 | 2 | PF00316 | |
| Domain | FBPASE | 4.96e-05 | 2 | 132 | 2 | PS00124 | |
| Domain | FBPase_class-1 | 1.48e-04 | 3 | 132 | 2 | IPR000146 | |
| Domain | CTF_NFI | 2.95e-04 | 4 | 132 | 2 | PF00859 | |
| Domain | CTF_NFI_1 | 2.95e-04 | 4 | 132 | 2 | PS00349 | |
| Domain | CTF_NFI_2 | 2.95e-04 | 4 | 132 | 2 | PS51080 | |
| Domain | CTF/NFI_DNA-bd-dom | 2.95e-04 | 4 | 132 | 2 | IPR020604 | |
| Domain | NfI_DNAbd_pre-N | 2.95e-04 | 4 | 132 | 2 | PF10524 | |
| Domain | CTF/NFI | 2.95e-04 | 4 | 132 | 2 | IPR000647 | |
| Domain | CTF/NFI_DNA-bd_N | 2.95e-04 | 4 | 132 | 2 | IPR019548 | |
| Domain | CTF/NFI_DNA-bd_CS | 2.95e-04 | 4 | 132 | 2 | IPR019739 | |
| Domain | HnRNP_R/Q_splicing_fac | 4.89e-04 | 5 | 132 | 2 | IPR006535 | |
| Domain | Pyridoxal-P_BS | 4.89e-04 | 5 | 132 | 2 | IPR021115 | |
| Domain | CP2 | 7.30e-04 | 6 | 132 | 2 | PF04516 | |
| Domain | CP2 | 7.30e-04 | 6 | 132 | 2 | IPR007604 | |
| Domain | DAD_dom | 1.35e-03 | 8 | 132 | 2 | IPR014767 | |
| Domain | DAD | 1.35e-03 | 8 | 132 | 2 | PS51231 | |
| Domain | PyrdxlP-dep_de-COase | 1.35e-03 | 8 | 132 | 2 | IPR002129 | |
| Domain | Pyridoxal_deC | 1.35e-03 | 8 | 132 | 2 | PF00282 | |
| Domain | DDC_GAD_HDC_YDC | 1.35e-03 | 8 | 132 | 2 | PS00392 | |
| Domain | SPEC | 1.47e-03 | 32 | 132 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.47e-03 | 32 | 132 | 3 | IPR018159 | |
| Domain | - | 1.91e-03 | 35 | 132 | 3 | 3.90.1150.10 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 2.08e-03 | 36 | 132 | 3 | IPR015422 | |
| Domain | MIR | 2.15e-03 | 10 | 132 | 2 | PF02815 | |
| Domain | MIR_motif | 2.15e-03 | 10 | 132 | 2 | IPR016093 | |
| Domain | MIR | 2.15e-03 | 10 | 132 | 2 | PS50919 | |
| Domain | MIR | 2.15e-03 | 10 | 132 | 2 | SM00472 | |
| Domain | Adenylat/UMP-CMP_kin | 2.15e-03 | 10 | 132 | 2 | IPR000850 | |
| Domain | - | MPP1 EFL1 ABCA13 WRN AK9 OLA1 DNAH1 NLRP14 AK1 CHD6 PALS2 DDX21 DNAH6 | 2.42e-03 | 746 | 132 | 13 | 3.40.50.300 |
| Domain | GBD/FH3_dom | 2.62e-03 | 11 | 132 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 2.62e-03 | 11 | 132 | 2 | PS51232 | |
| Domain | Elongated_TPR_rpt_dom | 2.62e-03 | 11 | 132 | 2 | IPR023114 | |
| Domain | - | 2.62e-03 | 39 | 132 | 3 | 3.40.640.10 | |
| Domain | P-loop_NTPase | MPP1 EFL1 ABCA13 WRN AK9 OLA1 IQGAP1 DNAH1 NLRP14 AK1 CHD6 PALS2 DDX21 DNAH6 | 2.71e-03 | 848 | 132 | 14 | IPR027417 |
| Domain | PyrdxlP-dep_Trfase | 3.02e-03 | 41 | 132 | 3 | IPR015424 | |
| Domain | PyrdxlP-dep_Trfase_major_sub1 | 3.02e-03 | 41 | 132 | 3 | IPR015421 | |
| Domain | ARM-like | 3.11e-03 | 270 | 132 | 7 | IPR011989 | |
| Domain | MAD_homology1_Dwarfin-type | 3.12e-03 | 12 | 132 | 2 | IPR003619 | |
| Domain | DWA | 3.12e-03 | 12 | 132 | 2 | SM00523 | |
| Domain | MH1 | 3.12e-03 | 12 | 132 | 2 | PF03165 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.27e-03 | 14 | 132 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.27e-03 | 14 | 132 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.27e-03 | 14 | 132 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.27e-03 | 14 | 132 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.27e-03 | 14 | 132 | 2 | IPR011704 | |
| Domain | MT | 4.27e-03 | 14 | 132 | 2 | PF12777 | |
| Domain | AAA_8 | 4.27e-03 | 14 | 132 | 2 | PF12780 | |
| Domain | AAA_5 | 4.27e-03 | 14 | 132 | 2 | PF07728 | |
| Domain | DHC_fam | 4.90e-03 | 15 | 132 | 2 | IPR026983 | |
| Domain | FH2 | 4.90e-03 | 15 | 132 | 2 | PS51444 | |
| Domain | Dynein_heavy | 4.90e-03 | 15 | 132 | 2 | PF03028 | |
| Domain | FH2_Formin | 4.90e-03 | 15 | 132 | 2 | IPR015425 | |
| Domain | FH2 | 4.90e-03 | 15 | 132 | 2 | PF02181 | |
| Domain | Dynein_heavy_dom | 4.90e-03 | 15 | 132 | 2 | IPR004273 | |
| Domain | FH2 | 4.90e-03 | 15 | 132 | 2 | SM00498 | |
| Domain | - | 4.99e-03 | 222 | 132 | 6 | 1.25.10.10 | |
| Domain | Guanylate_kinase_CS | 5.58e-03 | 16 | 132 | 2 | IPR020590 | |
| Domain | SANT/Myb | 5.92e-03 | 52 | 132 | 3 | IPR001005 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FYCO1 OLA1 PRPF8 CYFIP2 IQGAP1 DNAH1 S100P NAA35 DUOX1 FBP1 NANS PALS2 SPAG17 ATP2A2 GCN1 KYNU | 1.20e-07 | 807 | 136 | 16 | 30575818 |
| Pubmed | PMS1 BDP1 SPTB SLC30A8 FHOD3 C8orf34 ITPR1 RSBN1 S100P CTCFL FBP1 OSMR AP4B1 SPAG17 TRAPPC9 RSBN1L | 1.35e-07 | 814 | 136 | 16 | 23251661 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MPP1 ICE2 OLA1 PRPF8 MBD3 CYFIP2 SARS1 SFXN3 EIF5 POLR1B DDX21 ATP2A2 GCN1 HNRNPR | 1.04e-06 | 724 | 136 | 14 | 36232890 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 TRPC4AP TSHZ2 FOSL2 SPTB FRYL BTBD9 DNAH1 NFIB PCNX4 NFIC SFXN3 CHD6 ZNF84 ALCAM DAAM1 PALS2 TATDN1 TRAPPC9 AFF4 | 1.46e-06 | 1489 | 136 | 20 | 28611215 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ADCY4 VRK1 ZNF280C UNC45A OLA1 GRM1 PRPF8 MBD3 YARS1 CYFIP2 IQGAP1 GBA3 SARS1 SFXN3 EIF5 DDX21 ATP2A2 GCN1 HNRNPR | 3.06e-06 | 1425 | 136 | 19 | 30948266 |
| Pubmed | PMS1 MBD3 IQGAP1 FOCAD RSBN1 NLRP14 DDX21 ATP2A2 RSBN1L HNRNPR | 5.40e-06 | 411 | 136 | 10 | 36652389 | |
| Pubmed | 1.26e-05 | 76 | 136 | 5 | 36560452 | ||
| Pubmed | ADCY4 LRCH2 KALRN SPTB OLA1 GRM1 SLC1A2 YARS1 CYFIP2 IQGAP1 SARS1 SFXN3 OSBPL10 ATP2A2 DNAH6 ARHGAP21 TRAPPC9 HNRNPR | 1.26e-05 | 1431 | 136 | 18 | 37142655 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MACC1 SPAG1 UNC45A SCEL OLA1 IQGAP1 S100P EIF5 DAAM1 GCN1 ARHGAP21 | 1.48e-05 | 565 | 136 | 11 | 25468996 |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 24486508 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 10773464 | ||
| Pubmed | Noncanonical EF-hand motif strategically delays Ca2+ buffering to enhance cardiac performance. | 1.52e-05 | 2 | 136 | 2 | 23396207 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 20008467 | ||
| Pubmed | Various fructose-1,6-bisphosphatase mRNAs in mouse brain, liver, kidney and heart. | 1.52e-05 | 2 | 136 | 2 | 9106734 | |
| Pubmed | Reduced SERCA2 abundance decreases the propensity for Ca2+ wave development in ventricular myocytes. | 1.52e-05 | 2 | 136 | 2 | 20019150 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 18500823 | ||
| Pubmed | Separate mechanisms cause anemia in ischemic vs. nonischemic murine heart failure. | 1.52e-05 | 2 | 136 | 2 | 20032264 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 35597866 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 19328205 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 20864565 | ||
| Pubmed | The role of liver fructose-1,6-bisphosphatase in regulating appetite and adiposity. | 1.52e-05 | 2 | 136 | 2 | 22517657 | |
| Pubmed | Characterization of the mouse liver fructose-1,6-bisphosphatase gene. | 1.52e-05 | 2 | 136 | 2 | 11250076 | |
| Pubmed | Oxidative stress diverts tRNA synthetase to nucleus for protection against DNA damage. | 1.52e-05 | 2 | 136 | 2 | 25284223 | |
| Pubmed | S100P is a novel interaction partner and regulator of IQGAP1. | 1.52e-05 | 2 | 136 | 2 | 21177863 | |
| Pubmed | Increased glucose production in mice overexpressing human fructose-1,6-bisphosphatase in the liver. | 1.52e-05 | 2 | 136 | 2 | 18780768 | |
| Pubmed | Transcriptional diversity during lineage commitment of human blood progenitors. | 1.52e-05 | 2 | 136 | 2 | 25258084 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 19894134 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 24223976 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 24359226 | ||
| Pubmed | Fructose bisphosphatase isozymes of the mouse. I. Inheritance. | 1.52e-05 | 2 | 136 | 2 | 2996484 | |
| Pubmed | High-intensity exercise training in mice with cardiomyocyte-specific disruption of Serca2. | 1.52e-05 | 2 | 136 | 2 | 20167673 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 34363719 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 15971254 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.56e-05 | 202 | 136 | 7 | 33005030 | |
| Pubmed | 1.89e-05 | 288 | 136 | 8 | 38496616 | ||
| Pubmed | RNF121 MACC1 FOSL2 WRN UNC45A OLA1 MBD3 CYFIP2 IQGAP1 RSBN1 NFIB EIF5 POLR1B CHD6 DAAM1 ATP2A2 RSBN1L AFF4 | 2.29e-05 | 1497 | 136 | 18 | 31527615 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KALRN FOSL2 ARHGAP17 FYCO1 FRYL MBD3 FOCAD FAT1 C2CD3 SLC45A3 PCNX4 GCN1 MYRF ARHGAP21 TRAPPC9 | 2.96e-05 | 1105 | 136 | 15 | 35748872 |
| Pubmed | PMS1 NAT14 TRPC4AP CAMK4 UNC45A PRPF8 MBD3 YARS1 ITPR1 PCNX4 CHD6 ARHGAP21 | 4.33e-05 | 754 | 136 | 12 | 35906200 | |
| Pubmed | KALRN SPTB MCF2L2 PRPF8 YARS1 IQGAP1 FOCAD DGLUCY PPP1R16B CHD6 ZNF84 PALS2 ATP2A2 ARHGAP21 RSBN1L AFF4 | 4.47e-05 | 1285 | 136 | 16 | 35914814 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 27079415 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 29301499 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 28714958 | ||
| Pubmed | Ezrin interacts with the scaffold protein IQGAP1 and affects its cortical localization. | 4.54e-05 | 3 | 136 | 2 | 25554515 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 26069269 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 26461521 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 34644107 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 12549979 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 18809517 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 16831572 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 9099724 | ||
| Pubmed | EFL1 VRK1 UNC45A OLA1 PRPF8 MBD3 YARS1 IQGAP1 S100P NANS NFIB NFIC AK1 KYNU | 4.62e-05 | 1014 | 136 | 14 | 32416067 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | KALRN CAMK4 FBP2 SCEL OLA1 SLC36A2 CYFIP2 IQGAP1 S100P FAT1 FBP1 AK1 ALCAM UEVLD | 4.72e-05 | 1016 | 136 | 14 | 19056867 |
| Pubmed | 7.39e-05 | 21 | 136 | 3 | 33805532 | ||
| Pubmed | LRCH2 ARHGAP17 OLA1 PRPF8 MBD3 YARS1 CYFIP2 IQGAP1 DDX21 GCN1 ARHGAP21 HNRNPR | 8.45e-05 | 809 | 136 | 12 | 32129710 | |
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 15140926 | ||
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 29158260 | ||
| Pubmed | Nuclear factor one transcription factors as epigenetic regulators in cancer. | 9.06e-05 | 4 | 136 | 2 | 28076901 | |
| Pubmed | Transcription factor NF 1 expression in involuting mammary gland. | 9.06e-05 | 4 | 136 | 2 | 10959417 | |
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 7590749 | ||
| Pubmed | RFX1 and NF-1 associate with P sequences of the human growth hormone locus in pituitary chromatin. | 9.06e-05 | 4 | 136 | 2 | 12624117 | |
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 9052991 | ||
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 18480293 | ||
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 9056636 | ||
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 12568726 | ||
| Pubmed | Identification of a conserved family of Meis1-related homeobox genes. | 9.06e-05 | 4 | 136 | 2 | 9049632 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PMS1 VRK1 ZNF280C PRPF8 MBD3 CYFIP2 RSBN1 EIF5 DDX21 ATP2A2 RSBN1L AFF4 HNRNPR | 9.95e-05 | 954 | 136 | 13 | 36373674 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.11e-04 | 475 | 136 | 9 | 31040226 | |
| Pubmed | 1.11e-04 | 24 | 136 | 3 | 24347629 | ||
| Pubmed | 1.13e-04 | 120 | 136 | 5 | 27320910 | ||
| Pubmed | UNC45A OLA1 PRPF8 CYFIP2 IQGAP1 DNAH1 S100P SARS1 ERAP2 DDX21 ATP2A2 GCN1 AFF4 CDK3 HNRNPR | 1.15e-04 | 1247 | 136 | 15 | 27684187 | |
| Pubmed | OLA1 PRPF8 YARS1 IQGAP1 SARS1 EIF5 DDX21 ATP2A2 GCN1 ACSL5 HNRNPR | 1.17e-04 | 711 | 136 | 11 | 33022573 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | SPTB WRN SCEL OLA1 PRPF8 IQGAP1 C2CD3 SERPINC1 DDX21 GCN1 ARHGAP21 | 1.50e-04 | 732 | 136 | 11 | 34732716 |
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 22990596 | ||
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 24658146 | ||
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 18434517 | ||
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 39056782 | ||
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 22355118 | ||
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 19706729 | ||
| Pubmed | MACC1 SPAG1 PRPF8 CYFIP2 IQGAP1 C2CD3 AK1 CHD6 ZNF84 ALCAM SPAG17 DDX21 ATP2A2 DNAH6 ARHGAP21 HNRNPR | 1.70e-04 | 1442 | 136 | 16 | 35575683 | |
| Pubmed | Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. | 1.78e-04 | 28 | 136 | 3 | 19596686 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | RNF121 PRPF8 CYFIP2 IQGAP1 ITPR1 RSBN1 DGLUCY FAT1 ALDH1L2 CPT1C SFXN3 ATP2A2 DNAH6 TRAPPC9 SDF2 ACSL5 | 1.82e-04 | 1451 | 136 | 16 | 30550785 |
| Pubmed | 2.03e-04 | 405 | 136 | 8 | 38187761 | ||
| Pubmed | 2.25e-04 | 6 | 136 | 2 | 34854226 | ||
| Pubmed | gp130 Controls Cardiomyocyte Proliferation and Heart Regeneration. | 2.25e-04 | 6 | 136 | 2 | 32600062 | |
| Pubmed | 2.25e-04 | 6 | 136 | 2 | 12666198 | ||
| Pubmed | 2.25e-04 | 6 | 136 | 2 | 9808459 | ||
| Pubmed | 2.25e-04 | 6 | 136 | 2 | 21270437 | ||
| Pubmed | PMS1 ERCC4 ITPR1 SULF2 OSBPL10 AP4B1 KYNU ARHGAP21 RSBN1L GNPAT | 2.51e-04 | 650 | 136 | 10 | 38777146 | |
| Pubmed | 2.66e-04 | 655 | 136 | 10 | 35819319 | ||
| Pubmed | Proteomic analysis of complexes formed by human topoisomerase I. | 2.67e-04 | 32 | 136 | 3 | 15848144 | |
| Pubmed | Proteomic analysis identifies novel binding partners of BAP1. | 2.81e-04 | 80 | 136 | 4 | 34591877 | |
| Pubmed | 3.15e-04 | 7 | 136 | 2 | 27907249 | ||
| Pubmed | Identification of toposome, a novel multisubunit complex containing topoisomerase IIalpha. | 3.15e-04 | 7 | 136 | 2 | 15034300 | |
| Pubmed | 3.15e-04 | 7 | 136 | 2 | 10762365 | ||
| Pubmed | TGF-β/NF1/Smad4-mediated suppression of ANT2 contributes to oxidative stress in cellular senescence. | 3.15e-04 | 7 | 136 | 2 | 25220407 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | VRK1 LRCH2 KALRN PRPF8 MBD3 SULF2 SFXN3 CHD6 DDX21 ATP2A2 GCN1 AFF4 HNRNPR | 3.38e-04 | 1082 | 136 | 13 | 38697112 |
| Pubmed | 3.38e-04 | 437 | 136 | 8 | 20562859 | ||
| Pubmed | 3.82e-04 | 156 | 136 | 5 | 22952844 | ||
| Pubmed | 3.86e-04 | 241 | 136 | 6 | 23125841 | ||
| Pubmed | LRCH2 KALRN FYCO1 BTBD9 GRM1 SLC1A2 MBD3 CYFIP2 IQGAP1 SFXN3 ARHGAP21 AFF4 | 4.16e-04 | 963 | 136 | 12 | 28671696 | |
| GeneFamily | Fructose-1,6-bisphosphatases | 2.13e-05 | 2 | 84 | 2 | 1075 | |
| GeneFamily | Adenylate kinases | 7.52e-04 | 9 | 84 | 2 | 356 | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.43e-10 | 197 | 136 | 10 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | NS-moderate-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.11e-08 | 199 | 136 | 9 | aa2b51940115c22768c0d7493b4b60d41df3f376 | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.92e-07 | 200 | 136 | 8 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.92e-07 | 200 | 136 | 8 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Nasal_Brush-Epithelial|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.92e-07 | 200 | 136 | 8 | 7911073119ee47a37b68b73fc54f063e902a5067 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.19e-06 | 176 | 136 | 7 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-06 | 179 | 136 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.38e-06 | 180 | 136 | 7 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.38e-06 | 180 | 136 | 7 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.43e-06 | 181 | 136 | 7 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.43e-06 | 181 | 136 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-06 | 183 | 136 | 7 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-06 | 183 | 136 | 7 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 1.72e-06 | 186 | 136 | 7 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-06 | 186 | 136 | 7 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 187 | 136 | 7 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 187 | 136 | 7 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.91e-06 | 189 | 136 | 7 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-06 | 194 | 136 | 7 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 2.35e-06 | 195 | 136 | 7 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.43e-06 | 196 | 136 | 7 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.43e-06 | 196 | 136 | 7 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-06 | 197 | 136 | 7 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 2.51e-06 | 197 | 136 | 7 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-06 | 198 | 136 | 7 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | critical-Epithelial|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.69e-06 | 199 | 136 | 7 | bbb44e2a52f102a6d891ead6c06d6c07221abd33 | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.69e-06 | 199 | 136 | 7 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | moderate-Epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.78e-06 | 200 | 136 | 7 | 095783c9b75113ae350c2d5fb1195d71b41fa695 | |
| ToppCell | NS-moderate-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.78e-06 | 200 | 136 | 7 | 85940b4bf7971b872469dea8b8d7a45bdeb2a909 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.78e-06 | 200 | 136 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.78e-06 | 200 | 136 | 7 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.78e-06 | 200 | 136 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.53e-06 | 159 | 136 | 6 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.53e-06 | 159 | 136 | 6 | 00a157d033627d0e65c3fbd38d652c4cf56b47f6 | |
| ToppCell | 356C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-05 | 164 | 136 | 6 | b3192c443f4848e6a8afdb89c155f9ec42a154b0 | |
| ToppCell | 356C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-05 | 164 | 136 | 6 | f7288ec4daf494dae770ea6c58bead27660ccae1 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 168 | 136 | 6 | b9db0b1e4fe54a1fe79530d15d206155a1bfac39 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 168 | 136 | 6 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-05 | 169 | 136 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 176 | 136 | 6 | 533d544852038c0612aacf87f4b1c88ff7aace82 | |
| ToppCell | Children_(3_yrs)|World / Lineage, Cell type, age group and donor | 1.81e-05 | 178 | 136 | 6 | df2ecd3214590b914f2762db57efe780ba038db3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 181 | 136 | 6 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-05 | 183 | 136 | 6 | 5f2db95d44b7de68779de098892892af540fd431 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 2.18e-05 | 184 | 136 | 6 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 184 | 136 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 184 | 136 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 184 | 136 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.18e-05 | 184 | 136 | 6 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 2.25e-05 | 185 | 136 | 6 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 186 | 136 | 6 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 186 | 136 | 6 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-05 | 186 | 136 | 6 | 6d8dd6d0403d149cb6edb346581fe6c248036785 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 2.39e-05 | 187 | 136 | 6 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 2.39e-05 | 187 | 136 | 6 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-05 | 188 | 136 | 6 | ecc2364d946f97ae0212fd6739960c9fc75e4919 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.46e-05 | 188 | 136 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-05 | 189 | 136 | 6 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-05 | 189 | 136 | 6 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 189 | 136 | 6 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 189 | 136 | 6 | 3d838da870623a6a278ddc8e6cedca85d9877e50 | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.61e-05 | 190 | 136 | 6 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 190 | 136 | 6 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.61e-05 | 190 | 136 | 6 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.69e-05 | 191 | 136 | 6 | acd844b477a069b2dcf07b2998e1b5c87dc0eb94 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.69e-05 | 191 | 136 | 6 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 191 | 136 | 6 | 543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 2.69e-05 | 191 | 136 | 6 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 191 | 136 | 6 | 9d7d680da3979e256191b534ebd14c5383e0cf93 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 191 | 136 | 6 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 2.69e-05 | 191 | 136 | 6 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | Control-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 2.77e-05 | 192 | 136 | 6 | f95fb188aa642f3d0618242a770e7c4b70544adb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.77e-05 | 192 | 136 | 6 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.85e-05 | 193 | 136 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Control-Endothelial-Lymphatic|Control / Disease state, Lineage and Cell class | 2.85e-05 | 193 | 136 | 6 | 64d19be73e5432d491436a01da5de5c926b615a9 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.85e-05 | 193 | 136 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 2.85e-05 | 193 | 136 | 6 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.85e-05 | 193 | 136 | 6 | c3522693439c23830d8a3f20854539ccb7a666e0 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.85e-05 | 193 | 136 | 6 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 2.94e-05 | 194 | 136 | 6 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-05 | 194 | 136 | 6 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-05 | 194 | 136 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-05 | 195 | 136 | 6 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.02e-05 | 195 | 136 | 6 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 195 | 136 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.02e-05 | 195 | 136 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-05 | 195 | 136 | 6 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 3.02e-05 | 195 | 136 | 6 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-05 | 196 | 136 | 6 | ed76eeb37400ca154feae9b7ebaddb6c434f8b81 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 196 | 136 | 6 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.11e-05 | 196 | 136 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.11e-05 | 196 | 136 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.20e-05 | 197 | 136 | 6 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 3.29e-05 | 198 | 136 | 6 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.29e-05 | 198 | 136 | 6 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.29e-05 | 198 | 136 | 6 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.29e-05 | 198 | 136 | 6 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.29e-05 | 198 | 136 | 6 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.39e-05 | 199 | 136 | 6 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.39e-05 | 199 | 136 | 6 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 3.39e-05 | 199 | 136 | 6 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| Disease | restless legs syndrome (implicated_via_orthology) | 4.93e-06 | 8 | 133 | 3 | DOID:0050425 (implicated_via_orthology) | |
| Disease | urinary pH measurement | 2.00e-04 | 5 | 133 | 2 | EFO_0010136 | |
| Disease | fructose-1,6-bisphosphatase isozyme 2 measurement | 2.00e-04 | 5 | 133 | 2 | EFO_0802556 | |
| Disease | fructose-1,6-bisphosphatase 1 measurement | 2.99e-04 | 6 | 133 | 2 | EFO_0801606 | |
| Disease | Colorectal Carcinoma | KALRN ABCA13 SLC22A15 MCF2L2 WRN GRM1 C8orf34 FAT1 SPAG17 ACSL5 HDC | 3.50e-04 | 702 | 133 | 11 | C0009402 |
| Disease | juvenile idiopathic arthritis | 3.56e-04 | 74 | 133 | 4 | EFO_0002609 | |
| Disease | unipolar depression, age at onset | 7.83e-04 | 40 | 133 | 3 | EFO_0003761, EFO_0004847 | |
| Disease | aspartate aminotransferase measurement | BDP1 KALRN FOSL2 FYCO1 C8orf34 CD163 ITPR1 GBA3 DGLUCY ERAP2 GCN1 MMUT | 8.23e-04 | 904 | 133 | 12 | EFO_0004736 |
| Disease | motor function measurement | 1.08e-03 | 11 | 133 | 2 | EFO_0010749 | |
| Disease | hypothyroidism | 1.86e-03 | 284 | 133 | 6 | EFO_0004705 | |
| Disease | Schizophrenia | ABCA13 HTR3E LAMA2 BTBD9 GRM1 SLC1A2 CD163 FBP1 EIF5 ATP2A2 GNPAT | 2.23e-03 | 883 | 133 | 11 | C0036341 |
| Disease | Rolandic epilepsy | 2.32e-03 | 16 | 133 | 2 | Orphanet_1945 | |
| Disease | QRS duration | 2.37e-03 | 298 | 133 | 6 | EFO_0005055 | |
| Disease | Multiple congenital anomalies | 2.62e-03 | 17 | 133 | 2 | C0000772 | |
| Disease | caudal middle frontal gyrus volume measurement | 2.94e-03 | 18 | 133 | 2 | EFO_0010290 | |
| Disease | leukemia (implicated_via_orthology) | 3.28e-03 | 19 | 133 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | visual cortical surface area measurement | 3.63e-03 | 20 | 133 | 2 | EFO_0004771 | |
| Disease | waist-hip ratio | EFL1 NAT14 TSHZ2 MECOM SCEL C8orf34 MEIS2 DGLUCY CTCFL TTC39A ARHGAP21 RSBN1L HNRNPR | 3.67e-03 | 1226 | 133 | 13 | EFO_0004343 |
| Disease | serum metabolite measurement | RNF121 MROH9 ERCC4 GBA3 ERAP2 ALDH1L2 GADL1 ALCAM MYRF KYNU CFAP157 | 3.74e-03 | 945 | 133 | 11 | EFO_0005653 |
| Disease | Crohn's disease | 3.94e-03 | 441 | 133 | 7 | EFO_0000384 | |
| Disease | emphysema imaging measurement | 4.38e-03 | 146 | 133 | 4 | EFO_0007626 | |
| Disease | renal system measurement, blood urea nitrogen measurement | 4.39e-03 | 22 | 133 | 2 | EFO_0004741, EFO_0004742 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DVKVATDPKEVLLLM | 141 | Q8TBG9 | |
| LEEVKPLGEMETDLK | 1051 | A6H8Y1 | |
| EVKPVGKMETDLKEI | 1216 | A6H8Y1 | |
| EIDLKETGKRDIPIM | 1251 | A6H8Y1 | |
| IKELELMPEKGLKEE | 16 | Q8NI51 | |
| ELIPLCEKIGKIYEM | 71 | Q9NQ94 | |
| MKAKPDIISGEALIE | 956 | Q96NH3 | |
| FIIELMDVDKTPKGL | 126 | A5X5Y0 | |
| LAKEESFGPIMVISK | 821 | Q3SY69 | |
| KEGTDMFIIKAVLPV | 1016 | Q7Z2Z2 | |
| KNKIGPLFEELMTKL | 101 | Q49A92 | |
| TAFGLEELKECIKMP | 46 | P0DMQ9 | |
| MPYLGSEDVVKELKK | 1 | Q9Y6B7 | |
| IAEMSFVPKDKILEI | 2296 | Q86UQ4 | |
| PKELVLMLNELFGKF | 291 | Q8NFM4 | |
| VMIPGVTQLTEKDLK | 141 | Q6NUN0 | |
| MITQLKEGKFFLEDP | 186 | P56282 | |
| VLELPFKGDDITMVL | 301 | P01008 | |
| FKGDDITMVLILPKP | 306 | P01008 | |
| VVAVEPPLAKEMKEF | 26 | Q5JU67 | |
| DILLKAVGDTPIMKT | 56 | O94817 | |
| KEFFAELDKVMGPLI | 1121 | Q9UHB7 | |
| ILAPVVKEIMDDKSL | 1071 | P46940 | |
| DLVMVILFKGIPLES | 131 | O00712 | |
| MKGIVLFVSKVLEEP | 226 | Q99650 | |
| DEEMIGPIIDKLEKV | 156 | Q9NTK5 | |
| VADIAPGEELLLFMK | 176 | Q03112 | |
| LDILVVFMKGSPEEK | 841 | Q9NRD9 | |
| GLISLVKMKFLPVDD | 201 | P19113 | |
| MIDPVLGSIKTAKEL | 1611 | Q14517 | |
| EEKIPKTGLLMIALG | 191 | Q96M61 | |
| IAEELVKTMDLPKGL | 151 | O95983 | |
| IDKEEEKPVMLKIGT | 406 | Q14643 | |
| MVPKAVEDGIKVADL | 416 | Q16566 | |
| KLSEIMEKGQLVPLE | 56 | P00568 | |
| LKSGELMIKVPLTVD | 1341 | Q9BQS8 | |
| ISCLKGKMPIDLVID | 176 | O14770 | |
| TPDLIKIGMKLQEFF | 4566 | Q2LD37 | |
| GVMDPLDKVLSVLIK | 4971 | Q2LD37 | |
| MLDPALGEFVLVEKD | 186 | O00757 | |
| KEIKSIIDGYITPMD | 636 | Q86YR7 | |
| KPLVLEMLKAGVKDT | 16 | Q8WUY8 | |
| KLMIDKASLGPIEDF | 1031 | Q63HM2 | |
| TPIVMAGFLIEDKVI | 76 | Q8NH48 | |
| KIEVVMAEPLEKLLS | 31 | O94915 | |
| EPDPEVMAKVKVLFV | 331 | O43390 | |
| KGELKDGLEVMLSVP | 1436 | O60229 | |
| ISPKKADILDVVGML | 2871 | P24043 | |
| GLGVEKLEKLMPEIV | 1726 | Q92616 | |
| TVEVLEPEVTKLMKF | 111 | Q96F07 | |
| ILLILKGKPGEMEDT | 366 | Q5TGP6 | |
| EFLLMKVTEDPELKL | 11 | Q8NGA0 | |
| LLKFKAPIEEMEEKV | 546 | Q96T49 | |
| MLDPAIGEFILVDKD | 186 | P09467 | |
| DLIFLKGIMENPIVK | 21 | Q9NZW5 | |
| ALKKIRLDLEMEGVP | 31 | Q00526 | |
| QLDPSLGLMEKIKEL | 76 | Q8TCG5 | |
| EDLPKDMLEQLLKFV | 721 | Q9Y4D1 | |
| EKLVMEDIFISGDPL | 701 | Q9P2D7 | |
| KISLPVILMDETLKF | 971 | P16615 | |
| VDKMKLDLSALEPVL | 2706 | Q9C0G6 | |
| DVKAMGPLVLTEVLF | 271 | P55010 | |
| LTVLDEPLKFLGEMK | 321 | Q8N9C0 | |
| PFRVEMGLKLEKTLL | 206 | Q659A1 | |
| KFDPVGEILKMQDEL | 641 | Q659A1 | |
| GEILKMQDELLKPIS | 646 | Q659A1 | |
| VFDALMLKTPDLKGL | 526 | Q8TE85 | |
| EVFDALMLKTPSLKG | 541 | Q9NZI5 | |
| FGPLKVTMELITDNK | 691 | Q4AC94 | |
| KTLTPKFGLLNIVME | 251 | O15228 | |
| LPEFTEEEKKMIKGT | 286 | Q9H227 | |
| LCFLEKVGMPDEKSL | 1306 | Q8TD26 | |
| EVPEETKMVIKKGLE | 221 | P43004 | |
| KEGIEKILTMIPTDE | 996 | Q2V2M9 | |
| EKEKLEFMLVAHGPV | 176 | P15408 | |
| LKVIILMDPFDDDLK | 206 | Q9ULC5 | |
| LLLEMKIGAEVRKDP | 286 | Q6ZN28 | |
| LKAELVVFKGLMSDP | 261 | Q5TF58 | |
| LVPLMFGSLTVEKLK | 176 | O75608 | |
| MPKVKTIELEGGLLE | 236 | Q6P179 | |
| KVTEEPMGITLKLNE | 76 | Q00013 | |
| DEIKKREGFKLLMEP | 421 | Q6ZQY3 | |
| EFPLLLDIIKQEGKM | 3696 | Q8NDH2 | |
| ALPSVIKEEKMLGIL | 561 | Q7Z3D6 | |
| LGEEIDSKVKGMVFL | 661 | Q9NR30 | |
| AMKPIDGSKLLDFLI | 441 | Q13255 | |
| NKTFTLEKGLIVPME | 411 | Q96Q07 | |
| VSKFLPISGMEKEAI | 1131 | Q86VB7 | |
| LIVMFLPEKKDTGVF | 381 | Q8IZD6 | |
| ESLTLIVEGKPQIKM | 406 | Q13740 | |
| KIQDLLMSFGILKPD | 171 | P54277 | |
| LLKVVMKPIATVGES | 1386 | Q5VW36 | |
| LVSIPEEIGKLKDLM | 191 | Q5VUJ6 | |
| LELEKGKMPIDLVIE | 61 | A6NDR6 | |
| DLMLSFIVKDSPKLG | 981 | P0C091 | |
| VLDMLFPKFLKGLQD | 426 | Q96GQ5 | |
| TPVKMEILGKKDIET | 436 | Q5VWQ0 | |
| PVKMEILGKKDIETT | 426 | Q6PCB5 | |
| TEKGITVPEKLKEFM | 446 | P49591 | |
| PEMEPFKEKIGSFII | 826 | Q5TCS8 | |
| IKAMLESIGVPLEKL | 101 | P54577 | |
| LEVLKSIPSEKLMIE | 206 | Q6P1N9 | |
| AIPPLIMDTLEKKDF | 241 | Q9BWM7 | |
| GVKKEMIRLDEVPNL | 216 | Q8TEL6 | |
| FQGLPSKIDTLKEEM | 166 | Q68EM7 | |
| FESIGVVLPLENKMK | 276 | Q495M3 | |
| VAKVKIPEGTILTMD | 296 | Q9NR45 | |
| DKLVGITPQVMKDLI | 626 | Q8N3P4 | |
| EGKAAMLAPLLEVIK | 1206 | Q14191 | |
| DLVMVILFKGIPLES | 131 | P08651 | |
| MDLTKVVLPTFILEK | 411 | Q9BXB5 | |
| MEGIFMKPSELLKAE | 191 | Q99470 | |
| PLLLEVGVEEKFMTM | 41 | Q96JT2 | |
| KAIMDSGEKLTLPLI | 111 | Q6Q759 | |
| KFGDLILKATEPQMV | 1901 | Q6P2Q9 | |
| DGLMLKFVIPSEVKS | 576 | A0JNW5 | |
| ILKDFSILLMEGVPK | 266 | Q8IWU4 | |
| VGLCVAKPEMIFKLE | 66 | P51786 | |
| AIKEKEIPIEGLEFM | 51 | O43715 | |
| KIKDLTLPELIGIMD | 96 | Q5VZE5 | |
| IEDPAMKAFALGILK | 141 | Q5VZE5 | |
| KPLGVETKMILDELQ | 626 | O95171 | |
| KVILLDPSIIEAKME | 716 | Q07617 | |
| TMEFPEGDKVKVILS | 441 | Q86VQ3 | |
| LMSPEKFKLRGEQII | 516 | Q3MJ13 | |
| GELKVLMEKELPGFL | 31 | P25815 | |
| LLFKIKPEDAMDFGI | 166 | Q9H920 | |
| EIPKDEEGAIVMLKR | 1611 | P11277 | |
| TELGPLKEEEKLMKE | 646 | Q9NRE2 | |
| PGEIAKYMETVKLLD | 296 | Q99986 | |
| VMKPDVIFKLEQGEE | 51 | P51523 | |
| GLIKEMIAKFQEELP | 126 | Q8IX04 | |
| IKLENIGMEPLEKLE | 736 | Q96Q05 | |
| IGMEPLEKLEVTSKV | 741 | Q96Q05 | |
| PDMITKFLGVIVKSE | 261 | Q8ND82 | |
| KLTLTQMVGKPEELE | 491 | Q92889 | |
| TPGQLFLMFLKEKLE | 376 | Q9H9Y6 | |
| LEPMDTIFVKQVKEG | 96 | Q5T5U3 | |
| LEIITKAEEMLEKGP | 481 | Q5SRH9 | |
| DIPADMDGKSILKLL | 376 | Q8IWU5 | |
| MFQILLDPEEKGTEK | 156 | Q9H3U1 | |
| LGLQPKMVKTYLEEE | 76 | Q16719 | |
| PITVEMKGLKTDLDL | 91 | Q8TDW0 | |
| KLFLKETMEPEHGLT | 31 | Q86W24 | |
| KILFDGIPLEKMSVS | 171 | P22033 | |
| VKEILPEAVKDTGDM | 641 | Q9Y2G1 |